Our internationally recognized pediatric hematologists/oncologists and hematopathologists are world leaders in diagnosing and treating all types of pediatric blood cancers. In addition to treating lymphomas and leukemias, our pediatric hematologists/oncologists also treat histiocytosis, which is not a form of cancer but shares some of the characteristics of cancer and is often treated by pediatric hematologists/oncologists using some of the same therapies.
Center and Program Leadership
Andrew E. Place, MD, PhD
Vice President, Chief Medical Officer
Jessica A. Pollard, MD
Clinical Director of the Hematologic Malignancy Center
Acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloid malignancies, myeloproliferative disorders (CML, JMML, Down’s syndrome-associated Transient Myeloproliferative Disease, and other rare myeloid disorders)
Yana Pikman, MD
Co-Director of the Hematologic Malignancy Center (Basic & Translational Research)
Melissa Burns, MD
Early phase trials in high risk leukemia
Kimberly J. Davies, MD
Non-Hodgkin's lymphoma
Barbara A. Degar, MD
Langerhans cell histiocytosis (LCH), hemophagocytic lymphohistiocytosis (HLH)
Angela M. Feraco, MD, MMSc
Hodgkin lymphoma
Jennifer C. Kesselheim, MD, M.Ed
All types of leukemia and lymphoma, medical education
Lynda M. Vrooman, MD
Cancer survivorship and late effects of cancer treatment
